Usage patterns of paracetamol in France

British Journal of Clinical Pharmacology

Volumn , Issue , 2016, Pages 498-503

  Duong, Mai ^a   Gulmez, Sinem Ezgi ^a   Salvo, Francesco ^a   Abouelfath, Abdelilah ^a,b   Lassalle, Régis ^a,b   Droz, Cécile ^a,b   Blin, Patrick ^a,b   Moore, Nicholas ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b ADERA   (France)

Author keywords

adults; drug utilization; paracetamol; risk factors

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; CARDIOVASCULAR AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADOLESCENT; ADULT; AGED; ARTERY DISEASE; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; COHORT ANALYSIS; CONGENITAL HEART MALFORMATION; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; FRANCE; GROUPS BY AGE; HEALTH INSURANCE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; VALVULAR HEART DISEASE;

EID: 84978657376     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12957     Document Type: Article

References (25)

1. Green K, Drvota V, Vesterqvist O. Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). Prostaglandins 1989; 37: 311–5.
2. Hamlyn AN, Douglas AP, James O. The spectrum of paracetamol (acetaminophen) overdose: clinical and epidemiological studies. Postgrad Med J 1978; 54: 400–4.
3. Gulmez SE, Larrey D, Pageaux GP, Bernuau J, Bissoli F, Horsmans Y, et al. Liver transplant associated with paracetamol overdose: results from the seven-country SALT study. Br J Clin Pharmacol 2015; 80: 599–606.
4. Roberts E, Delgado Nunes V, Buckner S, Latchem S, Constanti M, Miller P, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis 2015; 75: 552–9.
5. Gulmez SE, Larrey D, Pageaux GP, Lignot S, Lassalle R, Jove J, et al. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study. Drug Saf 2013; 36: 135–44.
6. Moore A. Up to 4000 mg of paracetamol a day is ineffective for acute low back pain. Evid Based Med 2015; 20: 100.
7. da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of osteoarthritis pain: a network meta-analysis. Lancet 2016. doi: 10.1016/S0140-6736(16)30002-2.
8. Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin CW, Day RO, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ 2015; 350: h1225.
9. Moore RA, Derry S, Wiffen PJ, Straube S, Aldington DJ. Overview review: comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions. Eur J Pain 2015; 19: 1213–23.
10. Bailey E, Worthington HV, van Wijk A, Yates JM, Coulthard P, Afzal Z. Ibuprofen and/or paracetamol (acetaminophen) for pain relief after surgical removal of lower wisdom teeth. Cochrane Database Syst Rev 2013; 12: CD004624.
11. Derry S, Moore RA. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013; 4: CD008040.
12. Moore N, Gulmez SE, Larrey D, Pageaux GP, Lignot S, Lassalle R, et al. Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France. Pharmacoepidemiol Drug Saf 2013; 22: 160–7.
13. Curhan GC, Bullock AJ, Hankinson SE, Willett WC, Speizer FE, Stampfer MJ. Frequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US women. Pharmacoepidemiol Drug Saf 2002; 11: 687–93.
14. Duong M, Salvo F, Pariente A, Abouelfath A, Lassalle R, Droz C, et al. Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France. Br J Clin Pharmacol 2014; 77: 887–95.
15. Tuppin P, de Roquefeuil L, Weill A, Ricordeau P, Merliere Y. French national health insurance information system and the permanent beneficiaries sample. Rev Epidemiol Sante Publique 2010; 58: 286–90.
16. Moulis G, Lapeyre-Mestre M, Palmaro A, Pugnet G, Montastruc JL, Sailler L. French health insurance databases: what interest for medical research? Rev Med Interne 2015; 36: 411–7.
17. Bezin J, Pariente A, Lassalle R, Dureau-Pournin C, Abouelfath A, Robinson P, et al. Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France. Eur J Clin Pharmacol 2014; 70: 429–36.
18. Blin P, Dureau-Pournin C, Foubert-Samier A, Grolleau A, Corbillon E, Jove J, et al. Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database. Eur J Neurol 2015; 22: 464–71.
19. Blin P, Dureau-Pournin C, Lassalle R, Abouelfath A, Droz-Perroteau C, Moore N. A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation. Br J Clin Pharmacol 2016; 81: 569–78.
20. Moore N, Van Ganse E, Le Parc J, Wall R, Schneid H, Farhan M, et al. The PAIN study: paracetamol, aspirin and ibuprofen new tolerability study. A large scale, randomized clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for short-term analgesia. Clin Drug Investig 1999; 18: 89–98.
21. Moore N. Place of OTC analgesics and NSAIDs in osteoarthritis. Inflammopharmacology 2003; 11: 355–62.
22. Depont F, Fourrier A, Merliere Y, Droz C, Amouretti M, Begaud B, et al. Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the COX2 inhibitors and tNSAIDs description of users (CADEUS) study. Pharmacoepidemiol Drug Saf 2007; 16: 891–900.
23. Moore N, Verschuren X, Montout C, Callens J, Kong SX, Begaud B. Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice. Therapie 2000; 55: 133–6.
24. Blin P, Blazejewski S, Lignot S, Lassalle R, Bernard MA, Jayles D, et al. Effectiveness of antibiotics for acute sinusitis in real-life medical practice. Br J Clin Pharmacol 2010; 70: 418–28.
25. Davies RA, Maher CG, Hancock MJ. A systematic review of paracetamol for non-specific low back pain. Eur Spine J 2008; 17: 1423–30.